ARCHIVES

NCI Seeks CRADA Partners To Develop Targets Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

NCAB Oks Organ Systems Plan, Criteria For Starting, Ending Working Groups

October 7, 1988

Funding Opportunities (8-page issue).

April 25, 2003